Professional Documents
Culture Documents
NLR - Pregledni Rad Miodrag Kovacevic
NLR - Pregledni Rad Miodrag Kovacevic
Miodrag Kovačević
______________________________________________________________________________
UVOD supstance u neuromodulaciji i medijaciji
bihejvioralnih, neuroendokrinih I
Depresivni poremećaj je česta psihijatrijska
neurohemijskih karakteristika depresije
dijagnoza koja pogađa aproksimativno 3% -
(Schiepers et al. 2005).6 Pokazano je da su
10 % populacije uopšte. 1
brojni citokini, reaktanati akutne faze i
Prema različitim izvorima godišnja neuroinflamatorne supstance kao što su:
prevalence depresije u populaciji odraslih interleukini, C-reaktivni protein (CRP),
varira između 6% 12%, dok među odraslima kortizol i faktor tumorske nekroze-α
starijim od 65 godina varira između 5 %- povišeni kod pacijenata sa depresivnim
30%. Bazirano na procjenama Svjetske poremećajem. Imuni sistem se može menjati
zdravstvene organizacije (SZO), 350 sa depresijom i inflamatorni odgovor može
miliona ljudi širom svijeta pokazuju biti pokrenut u depresiji. 7
simptome depresije, dok depresivni
poremećaji predstavljaju 4,3% od global
burden svih bolesti. 2 Rizik od pojave
takozvane velike depresije tokom života je
procenjen na nivo od 8-12%. Depresija je
često udružena sa drugim somatskim
bolestima kao jedan od simptoma. To znači
da približno 10% odraslih (što odgovara
broju od 100 miliona slučajeva) pokazuju
znake depresije tokom jedne godine. Žene
pate od depresije duplo češće nego
muškarci.3
Neke neurobiološke hipoteze postuliraju
psihoneuroimunološku osnovu depresivnog
poremećaja.4 U etiologiji depresije nedavne Prilog 1: Neurorazvojna teorija depresije71
teorije govore u prilog da neuroinflmacija
ima ulogu u razvoju i održavanju Depresija je povezana sa perifernim imunim
poremećaja, kao I da poremećaj sam po sebi alteracijama, posebno sa inflamacijom
može da ima ulogu u alteraciji imunog niskog stepena. 8,9 Longitudinalne i
sistema i inflamatornih biomarkera. 5 eksperimentalne studije na ljudima i
Citokinska hipoteza depresije ukazuje na to životinjama sugerišu da postoji
da su proinflamatorni citokini ključne bidirekcionalna komunikacija mozak-imuni
sistem u kojoj poremećaji povezani sa
depresijom (npr. Kardiovaskularna inflamatornih molekula. 22.23 Sa druge strane,
oboljenja, metabolički sindrom) i periferni limfociti predstavljaju važnu protektivnu
inflamatorni signali vode depresiji i obrnuto. komponentu adaptivnog imunog odgovora.
10-14
Kardiovaskularna oboljenja, respiratorna 22
Prilog 3 : Komparacija broja krvnih ćelija kod bipolarnih pacijenata između manične i depresivne epizode 73
ZAKLJUČAK:
Neke neurobiološke hipoteze postuliraju poremećaja. Meta-analize pokazuju da je
psihoneuroimunološku osnovu depresivnog NLR povišen kod depresivnog i kod
poremećaja. Najčešće proučavani nekoliko drugih psihijatrijskih poremećaja.
inflamatorni biomarkeri depresije su IL-6 i Do sada nijedna studija nije istraživala
TNF Odnos Neutrofil-Limfocit povezanost između NLR s odgovorom na
(Neutrophil-to-lymphocyte ratio- NLR) antidepresive kod unipolarne depresije.
može biti dobar pokazatelj inflamatorne
patofiziologije depresivnog poremećaja.
NLR se određuje iz pune krvi, pa je jeftiniji i
lakši za tumačenje nego citokinska
testiranja. Do danas, nekoliko studija je
ispitivalo korisnost NLR, PLR i MLR kao
potencijalnih biomarkera bipolarnog
______________________________________________________________________________
REFERENCE
1. Muñoz RF, Cuijpers P, Smit F, Barrera AZ, Leykin Y. Prevention of major depression.
Annu Rev Clin Psychol 2010;6:181-212.
2. Docherty AR, Edwards AC, Yang F, Peterson RE, Sawyers C, Adkins DE et al. Age of
onset and family history as indicators of polygenic risk for major depression. Depress.
Anxiety 2017; 34(5): 446–452. Doi: 10.1002/da.22607
3. Kuehner C. Why is depression more common among women than among men? Lancet
Psychiatry2017; 4(2): 146–158.
4. Jaremka LM, Lindgren ME, Kiecolt-Glaser JK. Synergistic relationships among stress,
depression, and troubled relationships:ninsights from psychoneuroimmunology. Depress
Anxiety 2013;30:288-96.
5. Hurley LL, Tizabi Y. Neuroinflammation, neurodegeneration, and depression. Neurotox
Res 2013;23:131-44.
6. Schiepers OJG, Wichers MC, Maes M. Cytokines and major depression. Prog.Neuro-
Psychopharmacol Biol Psychiatry 2005; 29: 201-17.
7. Bobińska K, Gałecka E, Szemraj J, Gałecki P, Talarowska M. Is there a link between
TNF gene expression and cognitive deficits in depression? Acta Biochim. Pol. 2017;
64(1): 65–73.
8. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis
of cytokines in major depression. Biol Psychiatry (2010) 67:446–57.
doi:10.1016/j.biopsych.2009.09.033
9. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein,
IL-1, and IL-6: a meta-analysis. Psychosom Med (2009) 71:171–86.
doi:10.1097/PSY.0b013e3181907c1b
10. Stewart JC, Rand KL, Muldoon MF, Kamarck TW. A prospective evaluation of the
directionality of the depression-inflammation relationship. Brain Behav Immun (2009)
23:936–44. doi:10.1016/j.bbi.2009.04.011
11. Miller AH, Raison CL. The role of inflammation in depression: from evolutionary
imperative to modern treatment target. Nat Rev Immunol (2015) 16:22–34.
doi:10.1038/nri.2015.5
12. Kiecolt-Glaser JK, Derry HM, Fagundes CP. Inflammation: depression fans the flames
and feasts on the heat. Am J Psychiatry (2015) 172:1075–91.
doi:10.1176/appi.ajp.2015.15020152
13. Williams ED, Steptoe A. The role of depression in the etiology of acute coronary
syndrome. Curr Psychiatry Rep (2007) 9:486–92. doi:10.1007/ s11920-007-0066-y
14. Engler H, Brendt P, Wischermann J, Wegner A, Rohling R, Schoemberg T, et al.
Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation
in humans: association with depressive symptoms. Mol Psychiatry (2017) 22:1448–54.
doi:10.1038/mp.2016.264
15. Wiltink J, Beutel ME, Till Y, Ojeda FM, Wild PS, Münzel T et al. Prevalence of distress,
comorbid conditions and well being in the general population. J. Affect. Disord. 2011;
130(3): 429–437.
16. 4 Fond G, Lançon C, Auquier P, et al. C-Reactive protein as a peripheral biomarker in
schizophrenia. An updated systematic
review. Front Psychiatry 2018;9:392.
17. 5 Pinto JV, Moulin TC, Amaral OB. On the transdiagnostic nature of peripheral
biomarkers in major psychiatric disorders: a systematic review. Neurosci Biobehav Rev
2017;83:97–108.
18. Mayadas, T.N., Cullere, X., Lowell, C.A., 2014. The multifaceted functions of
neutrophils. Annu. Rev. Pathol. 9, 181–218.
20. 8 Mazza MG, Lucchi S, Tringali AGM, et al. Neutrophil/Lymphocyte ratio and
platelet/lymphocyte ratio in mood disorders: a meta-analysis. Prog
Neuropsychopharmacol Biol Psychiatry 2018;84:229–36.
22. Ivković, M.; Pantović-Stefanović, M.; Dunjić-Kostić, B.; Jurišić, V.; Lačković, M.;
Totić-Poznanović, S.; Jovanović, A.; Damjanović, A. Neutrophil-To-Lymphocyte Ratio
Predicting Suicide Risk in Euthymic Patients with Bipolar Disorder: Moderatory Effect
of Family History. Compr. Psychiatry 2016, 66, 87–95.
23. Rosales, C. Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Front. Physiol. 2018, 9, 113.
24. Zahorec R: Ratio of neutrophil to lymphocyte counts -rapid and simple parameter of
systemic inflammation and stress in critically ill. Bratislavské lekárske listy 2001; 102:5
14.
25. Jilma B, Blann A, Pernerstorfer T, Stohlawetz P, EichlerHG, Vondrovec B et al:
Regulation of adhesion molecules during human endotoxemia. No acute effects of
aspirin.Am J Respir Crit Care Med. 1999; 159:857-63
26. Azab B, Jaglall N, Atallah JP, Lamet A, Raja-Surya V,Farah B et al: Neutrophil
lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology
2001; 11:445-52
27. Szkandera J, Absenger G, Liegl-Atzwanger B, Pichler M, Stotz M, Samonigg H et al:
Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in
soft-tissue sarcoma patients. Br J Cancer 2013; 108:1677-83.
28. Seretis C, Gourgiotis S, Gemenetzis G, Seretis F, Lagoudianakis E & Dimitrakopoulos G:
The significance of neutrophil/lymphocyte ratio as a possible marker of underlying
papillary microcarcinomas in thyroidal goiters: a pilot study. Am J Surg 2013; 205:691-6.
29. Ayhan SS, Oztürk S, Erdem A, Ozlü MF, Ozyaşar M, Erdem K et al: Relation of
neutrophil/lymphocyte ratio with the presence and severity of coronary artery ectasia.
Turk Kardiyol Dern Ars 2013; 41:185-90
30. Puppe B, Tuchscherer M & Tuchscherer A: The effect of housing conditions and social
environment immediately after weaning on the agonistic behaviour, neutrophil/
lymphocyte ratio, and plasma glucose level in pigs. Livestock Prod Sci 1997; 48:157-64.
31. Kuyumcu ME, Yesil Y, Oztürk ZA, Kizilarslanoğlu C, Etgül S, Halil M et al: The
evaluation of neutrophillymphocyte ratio in Alzheimer's disease. Dement Geriatr Cogn
Disord 2012; 34:69-74.
32. . Semiz M, Yildirim O, Canan F, Demir S, Hasbek E, Tuman TC et al: Elevated
Neutrophil/Lymphocyte Ratio in Patients with Schizophrenia. Psychiatr Danub 2014;
26:220-5.
33. Turkmen K, Tonbul HZ, Toker A, Gaipov A, Erdur FM et al: The relationship between
oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal
disease patients. Ren Fail 2012; 34:1229-37.
34. Myint AM & Kim YK: Network beyond IDO in psychiatric disorders: revisiting
neurodegeneration hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 2014;
48:304-13
35. Zulfic, Z.; Weickert, C.S.; Weickert, T.W.; Liu, D.; Myles, N.; Galletly, C. Neutrophil–
lymphocyte ratio–a simple, accessible measure of inflammation, morbidity and prognosis
in psychiatric disorders? Australas. Psychiatry 2020, 28, 454–458.
36. Gibson PH, Croal BL, Cuthbertson BH, et al. Preoperative neutrophillymphocyte ratio
and outcome from coronary artery bypass grafting. Am Heart J 2007;154:995–1002
37. Özdin S, Sarisoy G, Böke Ömer. A comparison of the neutrophillymphocyte, platelet-
lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder
patients - a retrospective file review. Nord J Psychiatry 2017;71:509–12
38. Brinn A, Stone J. Neutrophil-lymphocyte ratio across psychiatric diagnoses: a cross-
sectional study using electronic health records. BMJ Open. 2020 Jul 19;10(7):e036859.
doi: 10.1136/bmjopen-2020-036859. PMID: 32690528; PMCID: PMC7371128.
39. Mert, D.G.; Terzi, H. Mean platelet volume in bipolar disorder: The search for an ideal
biomarker. Neuropsychiatr. Dis. Treat. 2016, 12, 2057–2062.
40. Özdin, S.; Sarisoy, G.; Böke, Ö. A Comparison of The Neutrophil-Lymphocyte, Platelet-
Lymphocyte and Monocyte-Lymphocyte Ratios in Schizophrenia And Bipolar Disorder
Patients—A Retrospective File Review. Nord. J. Psychiatry 2017, 71, 509–512. J. Clin.
Med. 2021, 10, 1924 12 of 13
41. Özdin, S.; Usta, M.B. A comparison of inflammatory markers in manic and euthymic
states of bipolar disorder. Nord. J. Psychiatry 2021, 75, 124–129.
42. Mayda, H.; Ahsen, A.; Bagcioglu, E.; Ozturk, A.; Bahceci, B.; Soyucok, E.; Baspinar,
E.; Ulu, M. Effect of Increased Neutro-phil-ToLymphocyte Ratio (NLR) And Decreased
Mean Platelet Volume (MPV) Values on Inflammation in Acute Mania. Noro Psikiyatr.
Ars. 2016, 53, 317–320.
43. Kalelioglu, T.; Akkus, M.; Karamustafalioglu, N.; Genc, A.; Genc, E.S.; Cansiz, A.;
Emul, M. Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation
markers for bipolar disorder. Psychiatry Res. 2015, 228, 925–927.
44. Inanli, I.; Aydin, M.; Çaliskan, A.M.; Eren, I. Neutrophil/lymphocyte ratio,
monocyte/lymphocyte ratio, and mean platelet volume as systemic inflammatory markers
in different states of bipolar disorder. Nord. J. Psychiatry 2019, 73, 372–379.
45. Ayhan, M.G.; Cicek, I.E.; Inanli, I.; Caliskan, A.M.; Ercan, S.K.; Eren, I.
Neutrophil/lymphocyte and platelet/lymphocyte ratios in all mood states of bipolar
disorder. Psychiatry Clin. Psychopharmacol. 2017, 27, 278–282.
46. Mazza, M.G.; Lucchi, S.; Tringali, A.G.M.; Rossetti, A.; Botti, E.R.; Clerici, M.
Neutrophil/lymphocyte ratio and
platelet/lymphocyte ratio in mood disorders: A meta-analysis. Prog. Neuro-
Psychopharmacol. Biol. Psychiatry 2018,84,229–236
47. Atli, A.; Demir, S.; Bulut, M.; Okan Ibilo˘glu, A.; Güne¸s, M.; Kaya, M.; Demirpençe,
Ö.; Sır, A. Neutrophil-Lymphocyte Ratio ˙In Patients With Major Depressive Disorder
Undergoing No Pharmacological Therapy. Neuropsychiatr. Dis. Treat. 2015, 11, 2253–
2258.
48. Kayhan, F.; Gündüz, ¸S.; Ersoy, S.A.; Kande˘ger, A.; Annagür, B.B. Relationships of
neutrophil–lymphocyte and platelet–lymphocyte ratios with the severity of major
depression. Psychiatry Res. 2017, 247, 332–335.
49. Sunbul, E.A.; Sunbul, M.; Yanartas, O.; Cengiz, F.; Bozbay, M.; Sari, I.; Güleç, H.
Increased Neutrophil/Lymphocyte Ratio in Patients with Depression is Correlated with
the Severity of Depression and Cardiovascular Risk Factors. Psychiatry Investig. 2016,
13, 121–126.
50. Arabska, J.; Łucka, A.; Magierski, R.; Sobów, T.; Wysoki´nski, A. Neutrophil-
lymphocyte ratio is increased in elderly patients with first episode depression, but not in
recurrent depression. Psychiatry Res. 2018, 263, 35–40.
51. Dionisie V, Filip GA, Manea MC, Movileanu RC, Moisa E, Manea M, Riga S, Ciobanu
AM. Neutrophil-to-Lymphocyte Ratio, a Novel Inflammatory Marker, as a Predictor of
Bipolar Type in Depressed Patients: A Quest for Biological Markers. J Clin Med. 2021
Apr 29;10(9):1924. doi: 10.3390/jcm10091924. PMID: 33946871; PMCID:
PMC8125288.
52. Fusar-Poli, L., Amerio, A., Cimpoesu, P., Grimaldi Filioli, P., Natale, A., Zappa, G.,
Aguglia, E., Amore, M., Serafini, G., & Aguglia, A. (2021). Gender Differences in
Complete Blood Count and Inflammatory Ratios among Patients with Bipolar
Disorder. Brain sciences, 11(3), 363
53. Sadock BJ, Sadock VA. Kaplan and Sadock’s Synopsis of Psychiatry.
9th ed. Lippincott,Williams and Wilkins, (Çev. ed.: Bozkurt A). Güneş
Tıp Kitabevleri. Ankara. 3:128–133;15:536–539.
54. Leonard BE. The immune system, depression and the action of antidepressants. Prog
Neuropsychopharmacol Biol Psychiatry. 2001;25:
767–780.
55. Raison CL, Miller AH. Is depression an inflammatory disorder? Curr
Psychiatry Rep. 2011;13:467–475.
56. Stein M, Miller AH, Trestman RL. Depression, the immune system,
and healthy and illness. Arch Gen Psychiatry. 1991;48:171–177.
57. Fonseka TM, Mclntyre RS, Soczynska JK, Kennedy SH. Novel investigational drugs
targeting IL-6 signaling for the treatment of depression. Expert Opin Investig Drugs.
2015;24(4):459–475.
58. Dowlati Y, Herrmann N, Swardfager W, et al. A metaanalysis of cytokines in major
depression. Biol Psychiatry. 2010;67:446–457.
59. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein,
IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71:171–186.
60. Kiecolt-Glaser JK, Marucha PT, Malarkey WB, Mercado AM, Glaser R.
Slowing of wound healing by psychological stress. Lancet. 1995;346:1194–1196
61. Sertöz ÖÖ, Mete HE. Bedensel Hastalıklarda Depresyon [Depression in somatic illness].
Klinik Psikiyatri. 2004;(Suppl)2:63–69. Turkish.
62. Rothermundt M, Arolt V, Fenker J, Gutbrodt H, Peters M, Kirchner H.Different immune
patterns in melancholic and non-melancholic major depression. Psychiatry Clin Neurosci.
2001;251:90–97.
63. Miller GE, Cohen S, Herbert TB. Pathways linking major depression
and immunity in ambulatory female patients. Psychosom Med. 1999;61:850–860.
64. Tuglu C, Kara SH. Depression, cytokines and immune system. Bull Clin
Psychopharmacol. 2003;13:142–150.
65. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H. Cytokine production
and serum proteins in depression. Scand J Immunol. 1995;41:534–538.
66. Zorrilla EP, Luborsky L, McKay JR, et al. The relationship of depression and stressors to
immunological assays: a metaanalytic review. BrainBehav İmmun. 2001;15:199–226.
67. Mc Adams C, Leonard BE. Neutrophil and monocyte phagocytosis in depressed patients.
Prog Neuropsychopharmacol Biol Psychiatry. 1993;17:971–984.
68. Demir S, Atli A, Bulut M, İbiloğlu AO, Güneş M, Kaya MC, Demirpençe Ö, Sır A.
Neutrophil-lymphocyte ratio in patients with major depressive disorder undergoing no
pharmacological therapy. Neuropsychiatr Dis Treat. 2015 Aug 27;11:2253-8. doi:
10.2147/NDT.S89470. PMID: 26347335; PMCID: PMC4556257.
69. Matthews KA, Gallo LC, Taylor SE. Are psychosocial factors mediators of
socioeconomic status and health connections? A progress report and blueprint for the
future. Ann N Y Acad Sci 2010;1186:146-
70. Maes M. Depression is an inflammatory disease, but cell-mediatedimmune activation is
the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry
2011;35:664-75.
71. Gałecki P, Talarowska M. Neurodevelopmental theory of depression. Prog.
Neuropsychopharmacol. Biol. Psychiatry 2018; 80(Pt C): 267–272.
72. Mert DG, Terzi H. Mean platelet volume in bipolar disorder: the search for an ideal
biomarker. Neuropsychiatr Dis Treat. 2016 Aug 16;12:2057-62. doi:
10.2147/NDT.S112374. PMID: 27578978; PMCID: PMC4998027
73. Fusar-Poli, L.; Natale, A.; Amerio, A.; Cimpoesu, P.; Grimaldi Filioli, P.; Aguglia, E.;
Amore, M.;Serafini, G.; Aguglia, A. Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte
and Monocyte-to-Lymphocyte Ratio in Bipolar Disorder. Brain Sci. 2021, 11,58.